Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”

被引：0
|
作者：
Sebastiano Bruno Solerte
Francesca D’Addio
Paolo Fiorina
机构：
[1] University of Pavia,Department of Internal Medicine, Geriatric and Diabetology Unit
[2] University of Pavia ASP-Pavia,School of Geriatrics
[3] Università di Milano,International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC L. Sacco
[4] ASST Fatebenefratelli-Sacco,Division of Endocrinology
[5] Harvard Medical School,Nephrology Division, Boston Children’s Hospital
来源：
Acta Diabetologica | 2021年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：247 / 248
页数：1
相关论文
共 50 条
  • [1] Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19"
    Solerte, Sebastiano Bruno
    D'Addio, Francesca
    Fiorina, Paolo
    ACTA DIABETOLOGICA, 2021, 58 (02) : 247 - 248
  • [2] Use of DPP-4 inhibitors in patients with COVID-19
    Kow, Chia Siang
    Hasan, Syed Shahzad
    ACTA DIABETOLOGICA, 2021, 58 (02) : 245 - 246
  • [3] Use of DPP-4 inhibitors in patients with COVID-19
    Chia Siang Kow
    Syed Shahzad Hasan
    Acta Diabetologica, 2021, 58 : 245 - 246
  • [4] DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
    Nag, Snehasish
    Mandal, Samanwita
    Mukherjee, Oindrila
    Mukherjee, Suprabhat
    Kundu, Rakesh
    FUTURE VIROLOGY, 2023, 18 (05) : 321 - 333
  • [5] The potential effects of DPP-4 inhibitors on cardiovascular system in COVID-19 patients
    Du, Hengzhi
    Wang, Dao Wen
    Chen, Chen
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (18) : 10274 - 10278
  • [6] In Reply to the Letter to the Editor Regarding "Aneurysmal Subarachnoid Hemorrhage in COVID-19 Patients: A Case Series"
    Dodd, William S.
    Chalouhi, Nohra
    WORLD NEUROSURGERY, 2021, 154 : 200 - 200
  • [7] A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
    Kow, Chia Siang
    Hasan, Syed Shahzad
    THERAPIE, 2021, 76 (04): : 361 - 364
  • [8] Reply to the Letter to the Editor "Pathogenesis of pneumoperitoneum in COVID-19 patients"
    Antonio Gemio del Rey, Ignacio
    de la Plaza Llamas, Roberto
    Manuel Ramia, Jose
    Medina Velasco, Anibal Armando
    CIRUGIA ESPANOLA, 2021, 99 (06): : 477 - 478
  • [9] HOSPITAL ADMISSION FOR COVID-19 AND USE OF DPP-4 INHIBITORS AS COMPARED TO OTHER GLUCOSE-LOWERING DRUGS
    Rodriguez-Martin, S.
    Rodriguez-Miguel, A.
    Lerma, V.
    Gil, M.
    Barreira-Hernandez, D.
    Carretero, A.
    de Abajo, F. J.
    GACETA SANITARIA, 2023, 37 : S78 - S79
  • [10] Clinical Use of DPP-4 Inhibitors
    Gallwitz, Baptist
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
12345